
The move appears to be an olive branch to the Federal Trade Commission, which could vote to block the $69 billion acquisition in a closed-door session on Thursday.
When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experim...
No comments:
Post a Comment